Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

March 5, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search